Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-News: Evotec receives € 150 m loan from European Investment Bank: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
EQS-News: Evotec receives € 150 m loan from European Investment Bank
EQS-News: Evotec receives € 150 m loan from European Investment Bank
SolarEdge and Freedom Forever Announce Multi-Year Agreement that Includes PV and Battery Storage Systems: https://mms.businesswire.com/media/20230209005471/en/1709956/5/Solaredge_Home_Battery.jpg
SolarEdge and Freedom Forever Announce Multi-Year Agreement that Includes PV and Battery Storage Systems


SolarEdge Technologies, Inc. (“SolarEdge”) (NASDAQ: SEDG), a global leader in smart energy technology, announced today that it entered into a multi-year agreement with Freedom Forever, a leading

PulteGroup Surprises U.S. Air Force Veteran with New Home in Southeast Florida: https://mms.businesswire.com/media/20230209005172/en/1709347/5/Photo.jpg
PulteGroup Surprises U.S. Air Force Veteran with New Home in Southeast Florida


A U.S. Air Force veteran and his wife received the news of a lifetime in the beginning of the new year. They were chosen to receive a brand-new mortgage-free home in Port St. Lucie, Florida

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-News: Delivery Hero concludes FY 2022 with further profitability improvement in Q4: https://www.deliveryhero.com/newsroom/downloads/
EQS-News: Delivery Hero concludes FY 2022 with further profitability improvement in Q4
EQS-News: Delivery Hero concludes FY 2022 with further profitability improvement in Q4
EQS-News: Evotec and Related Sciences expand integrated drug discovery and development partnership: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
EQS-News: Evotec and Related Sciences expand integrated drug discovery and development partnership
EQS-News: Evotec and Related Sciences expand integrated drug discovery and development partnership
LivaNova leitet die begrenzte Markteinführung des Essenz Perfusion System für kardiopulmonale Bypassverfahren in Europa ein: https://mms.businesswire.com/media/20230208005128/de/1707624/5/LIVN_Essenz_OR_team_2_CAPTION-One_of_the_first_clinical_cases_with_Essenz_at_San_Donato_Hospital%2C_Italy.jpg
LivaNova leitet die begrenzte Markteinführung des Essenz Perfusion System für kardiopulmonale Bypassverfahren in Europa ein


LivaNova PLC (Nasdaq: LIVN), ein marktführendes Unternehmen im Bereich Medizintechnik und Innovation, hat heute den Beginn einer begrenzten kommerziellen Freigabe für das Essenz™ Perfusion System*

LivaNova Initiates Limited Commercial Release in Europe of the Essenz Perfusion System for Cardiopulmonary Bypass Procedures: https://mms.businesswire.com/media/20230208005127/en/1707624/5/LIVN_Essenz_OR_team_2_CAPTION-One_of_the_first_clinical_cases_with_Essenz_at_San_Donato_Hospital%2C_Italy.jpg
LivaNova Initiates Limited Commercial Release in Europe of the Essenz Perfusion System for Cardiopulmonary Bypass Procedures


LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the start of a limited commercial release for the Essenz™ Perfusion System*. The release has

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-News: CANCOM: Second half-year brings 7.5 percent revenue growth. Executive Board announces programme to increase profitability.: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24051/375px-PLAN._BUILT._PERFORM..png
EQS-News: CANCOM: Second half-year brings 7.5 percent revenue growth. Executive Board announces programme to increase profitability.
EQS-News: CANCOM: Second half-year brings 7.5 percent revenue growth. Executive Board announces programme to increase profitability.
EQS-News: CANCOM: Second half-year brings 7.5 percent revenue growth. Executive Board announces programme to increase profitability.: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24051/375px-PLAN._BUILT._PERFORM..png
EQS-News: CANCOM: Second half-year brings 7.5 percent revenue growth. Executive Board announces programme to increase profitability.
EQS-News: CANCOM: Second half-year brings 7.5 percent revenue growth. Executive Board announces programme to increase profitability.
EQS-Adhoc: CANCOM SE: Revenue, ARR and gross profit reach target corridors for 2022. EBITDA and EBITA lower than forecast due to one-off special effects.: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24051/375px-PLAN._BUILT._PERFORM..png
EQS-Adhoc: CANCOM SE: Revenue, ARR and gross profit reach target corridors for 2022. EBITDA and EBITA lower than forecast due to one-off special effects.
EQS-Adhoc: CANCOM SE: Revenue, ARR and gross profit reach target corridors for 2022. EBITDA and EBITA lower than forecast due to one-off special effects.
EQS-Adhoc: CANCOM SE: Revenue, ARR and gross profit reach target corridors for 2022. EBITDA and EBITA lower than forecast due to one-off special effects.: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24051/375px-PLAN._BUILT._PERFORM..png
EQS-Adhoc: CANCOM SE: Revenue, ARR and gross profit reach target corridors for 2022. EBITDA and EBITA lower than forecast due to one-off special effects.
EQS-Adhoc: CANCOM SE: Revenue, ARR and gross profit reach target corridors for 2022. EBITDA and EBITA lower than forecast due to one-off special effects.
EQS-News: ENCAVIS AG acquires a German wind farm with a generation capacity of 11.2 MW for the first time after a repowering from Energiekontor: https://upload.wikimedia.org/wikipedia/commons/thumb/4/44/Encavis_logo.svg/1024px-Encavis_logo.svg.png
EQS-News: ENCAVIS AG acquires a German wind farm with a generation capacity of 11.2 MW for the first time after a repowering from Energiekontor
EQS-News: ENCAVIS AG acquires a German wind farm with a generation capacity of 11.2 MW for the first time after a repowering from Energiekontor
EQS-Adhoc: United Internet AG: Final offer price for IPO of IONOS Group SE set at EUR 18.50 per share : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24075/330px-UnitedInternet_logo.svg.png
EQS-Adhoc: United Internet AG: Final offer price for IPO of IONOS Group SE set at EUR 18.50 per share
EQS-Adhoc: United Internet AG: Final offer price for IPO of IONOS Group SE set at EUR 18.50 per share
EQS-Adhoc: United Internet AG: Final offer price for IPO of IONOS Group SE set at EUR 18.50 per share : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24075/330px-UnitedInternet_logo.svg.png
EQS-Adhoc: United Internet AG: Final offer price for IPO of IONOS Group SE set at EUR 18.50 per share
EQS-Adhoc: United Internet AG: Final offer price for IPO of IONOS Group SE set at EUR 18.50 per share
Bronson Healthcare and Acadia Healthcare Name Deb Rozewicz As CEO of Bronson Behavioral Health Hospital: https://mms.businesswire.com/media/20230207005432/en/1706665/5/ACHC_Rozewicz%2C_Deb_photo.jpg
Bronson Healthcare and Acadia Healthcare Name Deb Rozewicz As CEO of Bronson Behavioral Health Hospital


Bronson Healthcare and Acadia Healthcare Company have named Deb Rozewicz, RN, as chief executive officer for Bronson Behavioral Health Hospital, the 96-bed inpatient behavioral health hospital

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-News: Bechtle delivers strong 2022: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24050/225px-Bechtle_AG_20xx_logo.svg.png
EQS-News: Bechtle delivers strong 2022
EQS-News: Bechtle delivers strong 2022
EQS-News: Bechtle delivers strong 2022: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24050/225px-Bechtle_AG_20xx_logo.svg.png
EQS-News: Bechtle delivers strong 2022
EQS-News: Bechtle delivers strong 2022
EQS-News: Evotec SE: Laetitia Rouxel to succeed Enno Spillner as Chief Financial Officer: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
EQS-News: Evotec SE: Laetitia Rouxel to succeed Enno Spillner as Chief Financial Officer
EQS-News: Evotec SE: Laetitia Rouxel to succeed Enno Spillner as Chief Financial Officer
SolarEdge Launches its First Battery Virtual Power Plant Supporting Great Britain’s National Grid ESO Demand Flexibility Service: https://mms.businesswire.com/media/20230206005394/en/1706407/5/SolarEdge_Yorkshire_Image.jpg
SolarEdge Launches its First Battery Virtual Power Plant Supporting Great Britain’s National Grid ESO Demand Flexibility Service


SolarEdge Technologies, Inc. (“SolarEdge”) (NASDAQ: SEDG), a global leader in smart energy technology, today announced the launch of its first Battery Virtual Power Plant supporting Great Britain’s

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-News: Aurubis AG: Aurubis starts the new fiscal year strong with expected earnings at the upper end of the full-year forecast: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23699/Aurubis-Logo.svg.png
EQS-News: Aurubis AG: Aurubis starts the new fiscal year strong with expected earnings at the upper end of the full-year forecast
EQS-News: Aurubis AG: Aurubis starts the new fiscal year strong with expected earnings at the upper end of the full-year forecast